4 reports

The prominent features of this report are - ##.

  • Medical Biotechnology
  • Pharmaceutical
  • Targeted Therapy
  • Vaccine
  • World
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Musculoskeletal Disorder
  • Neurological Disorder
  • Targeted Therapy
  • Therapy
  • Vaccine
  • DORMANT PRODUCTS, H2 2019 (CONTD..1), H2 2019

## Total ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT BY STAGE OF DEVELOPMENT, H## 2019 Stage of Development Number of Products Under Development PRODUCTS UNDER DEVELO

  • Immunotherapy
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Vaccine

The key secondary endpoint is to delay or prevent terminal cardiac events (TCEs), defined as death, left ventricular assist device implantation, or heart transplant.

  • Clinical Trial
  • Orthopedics
  • Vaccine
  • United States
  • NuVasive, Inc.